CTRI/2018/03/012508
Recruiting
未知
Prospective Validation of Prediction algorithms for Preeclampsia in the first, second and third Trimesters of pregnancy
iona Chiu Yee Poon0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- iona Chiu Yee Poon
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •singleton pregnancy with live fetus
- •those who sign the Informed Consent Form
Exclusion Criteria
- •multiple pregnancy, non viable fetus and not signing the consent form
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Development and validation of prediction models for treatment failure of HFNC in COVID-19: a multicenter cohort studyCOVID-19JPRN-UMIN000050024Tohoku University300
Completed
Not Applicable
Prospective validation of a predictive model for pathologic complete response after chemoradiotherapy in rectal cancer: A prognostic studycancer of the rectum/rectumcancer1000211210017991NL-OMON33076MAASTRO clinic60
Completed
Not Applicable
Validating Artificial Intelligence Predictions of Postoperative Delirium after Cardiac SurgeryPostoperative DeliriumF05.0Delirium not superimposed on dementia, so describedDRKS00028749Institut für Anästhesiologie und SchmerztherapieHerz- und Diabeteszentrum NRW393
Completed
Not Applicable
Prospective study of evaluation to the predictive biomarker of Nivolumab by tumor tissue specimen and neighboring bronchoaveolar lavage fluid (BALF) and BloodJPRN-UMIN000023822Respiratory Medicine, Allergy and Rheumatic Diseases Osaka University Graduate School of Medicine20
Active, not recruiting
Phase 1
Assessment of a predictive response model for romiplostim in patients with low or intermediate-1 risk myelodysplastic syndrome (MDS) and thrombocytopenia - the EUROPE-trialPatients with IPSS low or intermediate-1 risk myelodysplastic syndrome (MDS) and thrombocytopeniaMedDRA version: 18.1Level: LLTClassification code 10068361Term: MDSSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2013-004328-12-FRGMIHO Gesellschaft für Medizinische Innovation - Hämatologie und Onkologie mbH90